Evaluation of First Trimester Uterine Artery Doppler, Placental Growth Factor and Maternal Characteristics in Prediction of Preeclampsia

EVALUATION OF MATERNAL SERUM ENDOGLIN IN PREECLAMPSIA AND IN NORMOTENSIVE PREGNANT FEMALES

Maternal Serum Vascular Endothelial Growth Factor in Patients with Preeclampsia

ROLE OF FIBROBLAST GROWTH FACTOR-21 IN WOMEN WITH PRE-ECLAMPSIA

Assessment of the Role of Maternal Angiogenic Factors and Nitric Oxide in Prediction of Preeclampsia

Assessment of placental protein 13 as a new marker for early diagnosis of preeclampsia

MATERNAL VASCULAR ENDOTHELIAL MARKERS IN PREGNANCIES COMPLICATED BY PRE-ECLAMPSIA

Evaluation of Serum Level of Soluble Suppressor Tumourginicity 2 (sST2) in Pregnancies Complicated by Preeclampsia

A New Predictor for Growth Restriction in Preeclampsia. A Case Control Study

Pregnancy-Associated Placental Protein A2/Placental Growth Factor Ratio Might Discriminate Normotensive Pregnant Women Who Are Liable to Develop Early-Onset Preeclampsia